16 August, 2017 Sobi Names Trista Morrison Vice President of Communications in North America 5 July, 2017 FDA grants SOBI003 Orphan Drug Designation for the treatment of MPS IIIA 30 May, 2017 Kineret® approved in Canada for the treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID) 28 February, 2017 FDA approves increased shelf life and in-use storage at room temperature for Orfadin® (nitisinone) 4 January, 2017 Health Canada approves Orfadin® capsules for treatment of hereditary tyrosinaemia type-1 (HT-1) 14 July, 2016 Health Canada validates Orfadin® capsule filing 15 June, 2016 Orfadin® 20 mg capsule approved in the US 26 April, 2016 Orfadin® Oral Suspension approved in the US 29 February, 2016 Sobi Partners with U.S. and Canadian Advocates, Legislators to Raise Awareness on Rare Disease Day® 23 February, 2016 Sobi™ to initiate clinical development programs in acute gout and Still's disease, and receives US patent on new formulation for Kineret® (anakinra) Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Next page Next › Last page Last »